Passa al contenuto
· Filler dermici
SKU 11114

Revanesse Shape™+

Disponibile
Volume
2 x 1,2 mL
Laboratorio
Prollenium Medical Technologies Inc.
Origine
Canada
Indicazione
Midface, jawline and chin structural support
Prezzo riservato e storico solo per account verificati
allpara rifornisce professionisti abilitati. Accedi o richiedi un account B2B per vedere prezzi in tempo reale, prezzi a scaglioni e storico dei prezzi.

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Principali vantaggi di Revanesse Shape™+

  • Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
  • Indicated for medium to deep facial rhytides and for lipoatrophy
  • Placed in the middle part of the dermis layer
  • Implantation life averages 6 to 12 months
  • Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
  • BDDE cross-linked in phosphate-buffered saline
  • CE marked 0653 for the syringe, with CE 0123 needles
Informazioni chiave
Marca REVANESSE
Produttore Prollenium Medical Technologies Inc.
Paese di origine Canada
Certificazione CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Composizione Cross-linked hyaluronic acid 25 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Volume / Formato 1.2 ml
Confezione 2 pre-filled syringes x 1.2 mL, with up to two sterilised 27G needles
Misura dell'ago 27G, up to two supplied
Tipo di utilizzo For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Profondità di iniezione Middle part of the dermis layer
Protocollo / Durata Implantation life averages 6 to 12 months, depending on the depth and location of injection

Indicazioni e uso professionale

Indicazioni principali

  • Medium to deep facial rhytides
  • Lipoatrophy

Uso professionale

For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

Aree di trattamento

  • Face

Profilo del paziente

For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

Come funziona Revanesse Shape™+ ​

Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.

Perché ordinare da Allpara

Allpara offre prodotti REVANESSE originali e verificati da fornitori selezionati, con tracciabilità completa dei lotti e supporto esperto. Serviamo cliniche e professionisti dell'estetica con prodotti certificati CE, consegna rapida in tutta l'UE dal nostro magazzino UE e prezzi riservati competitivi. La nostra priorità sono la sicurezza, la soddisfazione e i risultati dei tuoi pazienti - con un servizio post-vendita dedicato per la tua tranquillità.

Domande frequenti

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

/ Specifiche

La scheda tecnica

Categoria
Filler dermici
Marchio
REVANESSE
Laboratorio
Prollenium Medical Technologies Inc.
SKU
11114
Format
2 x 1,2 mL
Origine
Canada
Indication
Midface, jawline and chin structural support
Utilizzo
Professional hyaluronic acid dermal filler
/ Dettagli del prodotto

Il dossier completo

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Prollenium Medical Technologies Inc., paese di origine Canada.

Spedito in tutta l'UE dal nostro magazzino UE, tracciato e assicurato, con spedizione in 24-72h. Ogni unità viene spedita con numero di lotto e data di scadenza, in deposito doganale UE e tracciabile per lotto.

Conservare secondo le specifiche del produttore, al riparo dalla luce diretta. La catena del freddo viene utilizzata solo quando il prodotto lo richiede.

Termini di pagamento a 30 / 60 / 90 giorni* sono disponibili per gli account verificati previa approvazione del credito. La fatturazione è possibile in EUR, CHF e GBP.

I termini sono indicativi e vengono confermati dopo la verifica dell'account.

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

/ Risposte rapide

Le prime domande di ogni acquirente

How does Shape+ differ from Sculpt+?
They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.
What should a practitioner do if the skin blanches during injection?
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.
/ FAQ

Domande frequenti

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.
Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

Altri prodotti di Prollenium Medical Technologies

Vedi il laboratorio

Alternative per la clinica

Tutti i prodotti

Revanesse Shape™+

Disponibile
Marcatura CE Marcatura CE Revanesse Shape™+
Prezzi solo per account verificati
Accedi o richiedi un account B2B per vedere il tuo prezzo.
Richiedi l'account B2B

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Principali vantaggi di Revanesse Shape™+

  • Cross-linked hyaluronic acid 25 mg/mL with 0.3% lidocaine for injection comfort
  • Indicated for medium to deep facial rhytides and for lipoatrophy
  • Placed in the middle part of the dermis layer
  • Implantation life averages 6 to 12 months
  • Supplied as two 1.2 mL pre-filled syringes with up to two sterilised 27G needles
  • BDDE cross-linked in phosphate-buffered saline
  • CE marked 0653 for the syringe, with CE 0123 needles
Informazioni chiave
Marca REVANESSE
Produttore Prollenium Medical Technologies Inc.
Paese di origine Canada
Certificazione CE marked 0653 for the syringe. The needles supplied are CE marked 0123.
Composizione Cross-linked hyaluronic acid 25 mg/mL; lidocaine 0.3% w/w; in phosphate-buffered saline. Cross-linked with butanediol diglycidyl ether (BDDE).
Volume / Formato 1.2 ml
Confezione 2 pre-filled syringes x 1.2 mL, with up to two sterilised 27G needles
Misura dell'ago 27G, up to two supplied
Tipo di utilizzo For professional use - injectable dermal filler with lidocaine, injected only by or under the direct supervision of qualified physicians trained in the technique for filling facial wrinkles
Profondità di iniezione Middle part of the dermis layer
Protocollo / Durata Implantation life averages 6 to 12 months, depending on the depth and location of injection

Indicazioni e uso professionale

Indicazioni principali

  • Medium to deep facial rhytides
  • Lipoatrophy

Uso professionale

For professional use. Revanesse Shape+ should only be injected by or under the direct supervision of qualified physicians trained in the proper injection technique for filling facial wrinkles, and is not for retail sale or self-administration. It is placed in the middle part of the dermis layer. The area must be thoroughly disinfected and injection performed under sterile conditions; bring the product to room temperature for 30 minutes beforehand, prime the syringe until a small drop appears at the needle tip, and inject slowly with the least pressure necessary. If the skin blanches, stop immediately and massage until normal colour returns. It must not be injected into an area already containing another filler or a permanent implant, and must not contact quaternary ammonium salts such as benzalkonium chloride. Store between 2 and 25 degrees Celsius, protected from direct sunlight and freezing.

Aree di trattamento

  • Face

Profilo del paziente

For adult patients seeking correction of medium to deep facial rhytides or of lipoatrophy, as assessed by a qualified physician. Because it contains lidocaine, it is contraindicated in patients with hypersensitivity to any amide-type local anaesthetic. Further contraindications include hypertrophic scarring, acne or other inflammatory skin disease, acute or chronic skin disease at or near the injection site, auto-immune disorders or immunotherapy, multiple severe allergies, coagulation defects or anti-coagulation therapy, sensitivity to hyaluronic acid, and unattainable expectations. It contains trace amounts of gram-positive bacterial proteins and is contraindicated in patients allergic to such material. It must not be used during pregnancy or lactation, in anyone under 18, or in conjunction with laser, intense pulsed light, chemical peeling or dermabrasion.

Come funziona Revanesse Shape™+ ​

Shape+ is a cross-linked hyaluronic acid gel that occupies volume in the dermis where it is placed, correcting medium to deep rhytides and the volume loss of lipoatrophy. Because it is placed in the middle part of the dermis rather than superficially, how long it lasts depends on the depth and location of the injection, which is why it lasts 6 to 12 months rather than a fixed period. The 0.3% lidocaine is present for injection comfort, which makes hypersensitivity to amide-type anaesthetics an outright contraindication.

Perché ordinare da Allpara

Allpara offre prodotti REVANESSE originali e verificati, con tracciabilità completa dei lotti, stock certificato CE, consegna rapida in tutta l'UE e assistenza post-vendita esperta.

Domande frequenti

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

Altri prodotti di Prollenium Medical Technologies

Vedi il laboratorio →

Revanesse Shape+ is a colourless, odourless and transparent aqueous gel of synthetic origin from Prollenium Medical Technologies in Aurora, Canada, indicated for treating lipoatrophy and medium to deep facial rhytides. Its injection target is the middle part of the dermis layer, and the implant lasts 6 to 12 months on average. The gel is made of 25 mg/mL of hyaluronic acid, cross-linked with BDDE, and 0.3% lidocaine in phosphate-buffered saline, for professional use only. Every box holds two 1.2 mL syringes with up to two sterilised 27G needles.

Prollenium Medical Technologies Inc., paese di origine Canada.

Spedito in tutta l'UE dal nostro magazzino UE, spedizione in 24-72h, tracciato e assicurato. Ogni unità viene spedita con numero di lotto e data di scadenza, in deposito doganale UE e tracciabile per lotto. Conservare secondo le specifiche del produttore.

Pagamento a 30 / 60 / 90 giorni* per gli account verificati previa approvazione del credito. Fatturazione in EUR, CHF e GBP.

How does Shape+ differ from Sculpt+?

They share the same specification: 25 mg/mL cross-linked hyaluronic acid with 0.3% lidocaine, two 1.2 mL syringes with 27G needles, placed in the middle part of the dermis for medium to deep facial rhytides and lipoatrophy, lasting 6 to 12 months.

What should a practitioner do if the skin blanches during injection?

Stop the injection immediately and massage the area until the skin returns to its normal colour. Blanching can signal intravascular placement, which has been associated with embolisation, vision impairment, blindness, skin necrosis and stroke.

* Prodotto per uso professionale. La confezione può variare in base al lotto o al mercato. Consulta le istruzioni per l'uso fornite per le indicazioni complete e le controindicazioni.